Dr. Smiley-Byrd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
48 Hills Creek Road
Taylorsville, GA 30178
Summary
- Dr. Dawn Smiley-Byrd is a board-certified endocrinologist that has worked in Atlanta and the surrounding areas for over 20 years. She received her medical degree from the University of Alabama School of Medicine and completed her Endocrinology fellowship at Emory University School of Medicine. She later went on to obtain a Master's in Clinical Research from Emory University Laney Graduate School. Her past research has focused on diabetes and metabolic disorders but she also enjoys managing other endocrine disorders and teaching. She has presented at national and international conferences and she has authored/co-authored several publications.
Education & Training
- Emory University Laney Graduate SchoolMSCR, Clinical Research, 2006 - 2008
- Emory University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2005
- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine/Pediatrics, 1999 - 2003
- University of Alabama School of MedicineClass of 1999
Certifications & Licensure
- GA State Medical License 2003 - 2025
- OH State Medical License 1999 - 2003
Clinical Trials
- Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU Start of enrollment: 2006 Jun 01
- Ketosis Prone Diabetes in African-Americans Start of enrollment: 2007 May 01
- Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Estimation of glucose absorption, insulin sensitivity, and glucose effectiveness from the oral glucose tolerance test.Darko Stefanovski, Dawn D Smiley, Naresh M Punjabi, Guillermo E Umpierrez, Priyathama Vellanki
The Journal of Clinical Endocrinology and Metabolism. 2024-05-13 - 1 citations1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Survival in Obese Black Patients With Hyperglycemic Crises.Ram Jagannathan, Darko Stefanovski, Dawn D Smiley, Omolade Oladejo, Lucia F Cotten
Frontiers in Endocrinology. 2022-01-01 - 1 citationsPopulation Insulin Sensitivity from Sparsely Sampled Oral Glucose Tolerance TestsDarko Stefanovski, Priyathama Vellanki, Dawn Smiley-Byrd, Guillermo E. Umpierrez, Raymond C. Boston
Metabolism. 2020-06-20
Lectures
- Randomized, Controlled Trial of Intensive vs. Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery (GLUCO-CABG)Atlanta, GA - 6/13/2014
- Diabetes Care in Long-term Care Facilities: A Randomized, Controlled StudyAtlanta, GA - 6/14/2014
- Long-term Effects of Metformin and Sitagliptin on Near-Normoglycemic Remission, ß-Cell Function, and Insulin Sensitivity in Obese African Americans with Hyperglycemic ...Atlanta, GA - 6/15/2014
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: